Cognetivity Neurosciences Ltd. (CGNSF) is a publicly traded company in the Healthcare sector, operating within the Medical - Healthcare Information Services industry. The company is headquartered in Vancouver, BC, Canada. The current CEO is Sina Habibi.
CGNSF has IPO date of 2021-01-08, 2,500 full-time employees, listed on the Other OTC, a market capitalization of $8.96K.
Cognetivity Neurosciences Ltd. operates as a healthcare company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that helps to detect the earliest signs of impairment by testing the performance of large areas of the brain to support the diagnosis of dementia; and offers OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.
